Navigation Links
Pyrophosphate Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ADAM-12 (Meltrin alpha), amino terminal region Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products:
(Date:11/4/2009)...ember 4, 2009 Childhood obesity in the United Sta...an one fourth of advertising on daytime and prime ... continuing questions about the role television pl...ssue of the Journal of Nutrition Education and Be...ldren might be a large contributor to the problem....
(Date:11/4/2009)... Oct. 20 Quest Diagnosti... provider of diagnostic testing, information and s...d September 30, 2009, income from continuing opera...hare, from $160 million, or $0.81 per diluted shar...uarter results were reduced by a $0.03 per share c...
(Date:11/4/2009)...t. 26 BIO-key Internatio...finger-based biometric identification software is ... the AABB TXPO conference being held at the New Or...IO-key will provide hands-on product demonstration...y in booth #424. Also, at 5 PM on Monday, October ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2RMACT Celebrates Seven Years of Growing Families 57136 1RMACT Celebrates Seven Years of Growing Families 57136 2RMACT Celebrates Seven Years of Growing Families 57136 3RMACT Celebrates Seven Years of Growing Families 57136 4Treating bone loss in breast cancer survivors 9926 1Treating bone loss in breast cancer survivors 9926 2Ecosystem researchers to hold science briefing for policymakers 9925 1
...n in yeast, worms, and flies keeps blood sugar und...ust Cell Metabolism. The findings suggest therapeu... of metabolic disorders, such as type 2 diabetes, ...aid. , The team found that mice with an excess of ...proved glucose tolerance and enhanced insulin secr...
...ired infections can persist for days and even week...ttings, including bed linens, computer keyboard co...h presented today at the 105th General Meeting of ...in-resistant Staphylococcus aureus (MRSA) is a maj...ited States. Staphylococcal infections can cause c...
...,s motor nerve cells grow along proper paths durin... inhibiting spinal-cord neurons from regenerating ...al Center have found. In cultured cells, the resea...ce that normally insulates and stabilizes long ner...the ability of nerve cells to grow through myelin ...
Other Biology News:Sea Ice May Be on Increase in the Antarctic 2Researchers find molecule that inhibits regrowth of spinal nerve cells 2Researchers find molecule that inhibits regrowth of spinal nerve cells 3
(Date:11/6/2009)...EO, Calif., Nov. 6 ,...transfer of Qutenza(TM) E.U. Marketing Authorizati...nt progress in commercial readiness activities Ex... Director, Marketing; and Director, Commercial Ope... director and Audit Committee chairman , Up...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biote...e "Company") today announced updated results from ...ients with sarcomas metastatic to the lung in a po...ssue Oncology Society Meeting held in Miami Beach,...sentation, entitled "A Phase II Study of Intraveno...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010...ich is set to take place on February 22-24, 2010 i...day conference we will highlight key issues in for...share their experiences. , ...agenda for Arrowhead’s 2010 Personalized Me...
(Date:11/5/2009)...SBURG, Md., Nov. 5 GenVe...cial results for the third quarter ended September...ion ($0.04 per share) for the three months ended S...illion ($0.08 per share) in the comparable quarter...2009, GenVec,s net loss was $14.1 million ($0.15 p...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6